BacktoSchool

 

It’s That Time of Year Again!

Cardlytics does its homework and reports on what’s in store

for the second-biggest shopping season of the year.

By RM Staff

The kids might still be at camp, or the family vacation isn’t yet over. But, don’t look now: The back-to-school shopping season has begun!

Among the trends this year is the continuing migration of shoppers to online, with purely e-commerce retailers such as Amazon showing the fastest growth, according to marketing intelligence firm Cardlytics.

Cardlytics released its annual back-to-school data findings in July. It revealed five key findings based on its analysis of $2.4 trillion in purchase data across its banking partners.

1. Spending Grows – This will continue a trend from 2017-2018, when Cardlytics says total back-to-school spend grew by 2.5 percent. More shopping is getting done online, with purely e-commerce retailers capturing 17 percent of spend.

2. Don’t Count In-Store Out – Despite the continuing migration to online shopping, in-store spending still dominates. In fact, physical stores still account for nearly 80 percent of spending during this shopping season, Cardlytics says.

3. It’s Good to be Horizontal – General and multi-line retailers such as Target, Walmart and Amazon accounted for nearly 75 percent of all back-to-school spending last year. Cardlytics will be watching to see whether this trend holds true in 2019.

4. Omnichannel Shoppers are Key – Are you shopping for school supplies both online and in-store? If so, you help account for the 48 percent of spending that is driven by omnichannel shoppers.

5. Fall Sales Drive Loyalty – Cardlytics urges retailers keep the momentum going even when the back-to-school season ends. After all, you’ll see many of those same shoppers again when the holiday shopping season comes around later in the year. “Customers acquired during the fall spent 20 percent more overall than customers acquired in December,” the firm notes.

Want to know more? Visit https://www.cardlytics.com/blog/back-to-school-season-has-arrived/.

 

newswirelogo

  • SHANGHAI, China, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced that the first patient has been dosed in a Phase 1b/2 study evaluating FGF401 in combination with PD-1 inhibitor, pembrolizumab, in patients with advanced solid tumors, such as hepatocellular carcinoma (HCC).

  • 中国上海, Aug. 07, 2020 (GLOBE NEWSWIRE) -- 云顶新耀(Everest Medicines),一家专注于创新药开发及商业化的生物制药公司,致力于满足大中华区及其它亚洲市场未被满足的医疗需求,今日宣布在FGF401联合PD-1抑制剂Pembrolizumab用于治疗晚期实体瘤(例如肝细胞癌)的1b/2期临床研究中完成首例受试者给药。

  • HOUSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Houston Wire & Cable Company (NASDAQ: HWCC) (the “Company”) announced operating results for the second quarter ended June 30, 2020 and progress on its cost and debt reduction programs.

  • CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on developing proprietary technology to harness the power of the immune system to combat cancer, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $15.00 per share. All of the shares are being offered by Checkmate. Checkmate’s common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol “CMPI” on August 7, 2020. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Checkmate, are expected to be approximately $75,000,000. The offering is expected to close on August 11, 2020, subject to the satisfaction of customary closing conditions. Checkmate has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

  • AUSTIN, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- ESW Capital, LLC (“ESW”) – confirms that it has delivered today an application to the Ontario Securities Commission (the “OSC”) for an exemption from the “majority of the minority” requirement contained in Section 2.29.1(c) of National Instrument 62-104 (the “Exemption”) in connection with its previously announced intention to make an offer to acquire any and all subordinate voting shares (the “Shares”) in the capital of Optiva, Inc. (TSX:OPT) (“Optiva”) at the price of CAD $60 per Share (the “Offer”).

Contact Us

Retail Merchandiser Magazine

Cringleford Business Centre,
Intwood Road Cringleford,
Norwich, UK, NR6 4AU

  +44 (0) 1603 274 130

Click here for a full list of contacts.

Back To Top